Published on December 26th, 2020 by Aristofanis Papadatos
ServiceNow (NOW) has offered life-changing returns since its IPO in 2012. During this period, the stock has rallied more than 30-fold
News
What Is Time Value of Money?
What Is Time Value of Money? was originally published here.
if (typeof jQuery == 'undefined') { document.write('<scr' + 'ipt type="text/javascript"
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU)
Ennis Will Acquire Assets of Infoseal
Ennis, Inc. (the “Company"), (NYSE: EBF), today announced that one of its wholly owned subsidiaries has entered into a Letter of Intent to acquire the assets and assume some liabilities of Infoseal
Insight Awarded Global SASE Partner of the Year from Palo Alto Networks
Insight Enterprises (NASDAQ: NSIT), the global integrator of Insight Intelligent Technology Solutions™ for organizations of all sizes, was named Palo Alto Networks Global SASE Partner of the Year.
Pitney Bowes Announces Pricing Update for Delivery Services as Parcel Volumes Continue to Surge into 2021
Pitney Bowes Inc. (NYSE:PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced that pricing
Angelika Anywhere: Curated for Film Lovers
Reading International, Inc. (NASDAQ: RDI) announces the launch of Angelika Anywhere, a streaming platform curated for film lovers, as inspired by its Angelika Film Center in New York City, North
Clovis Oncology Submits Investigational New Drug Applications for Novel Peptide-Targeted Radionuclide FAP-2286 for Therapeutic and Imaging Clinical Trial
Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the company has completed submission of two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA) for
NCR is Global Leader in Restaurant POS Software According to Research and Consulting Firm RBR
NCR Corporation (NYSE: NCR) leads the global restaurant point-of-sale (POS) software market according to research and consulting firm RBR. The Global POS Software 2020 Report conducted by RBR
Eyenovia Submits New Drug Application to FDA for Pharmacologic Mydriasis with MydCombi Targeting 80 Million Patient Encounters in the U.S. Annually
Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company with Phase 3 programs in presbyopia, myopia and mydriasis, today announced that it has submitted a New Drug
Essex Property Trust Announces Executive Leadership Succession
Essex Property Trust, Inc. (NYSE:ESS) announced today the planned succession for the Chief Operating Officer (COO) and the Chief Financial Officer (CFO).
John Burkart will retire as the Company’s
LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for LORBRENA ® (lorlatinib) as
US Foods to Participate in the ICR Virtual Conference on Jan. 11, 2021
US Foods Holding Corp. (NYSE: USFD) Chairman and Chief Executive Officer, Pietro Satriano, and Chief Financial Officer, Dirk Locascio, will present at the ICR Conference on Monday, Jan. 11 at 1:30
Eurofins Genomics Launches Cost-Effective SARS-CoV-2 full-length Viral Genome Sequencing Services Essential in the Identification of Viral Mutations
Eurofins Genomics (Paris:ERF) launches an optimised, cost-effective, SARS-CoV-2, next-generation sequencing service providing full length viral genome sequences. The best-in-class ARTIC NGS Oligo
PRISMAFLEX INTERNATIONAL : Evolution in the capital standing for Anthem Displays
Prismaflex partner up with Circle Graphics and maintain a minority holding via their Prismaflex USA subsidiary of 28.91%.
Prismaflex International announce they have concluded an association
THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2021
Lyon, December 28, 2020 – Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates modulating the interaction
Polaris Schedules Fourth Quarter and Full Year 2020 Earnings Call and Webcast
Polaris Inc. (NYSE: PII) announced today that it will release its fourth quarter and full year 2020 financial results on Tuesday, January 26, 2021, and will hold a conference call and webcast at
Customers Bank Wins Prestigious Global Everbridge Critical Event Management Impact Award
Customers Bank was selected as the winner of the highly coveted 2020 Best Example of Making an Impact on Business Award presented by Everbridge, an organization focused on life-saving efforts
Foresight Autonomous Holdings Prices $26 Million Registered Direct Offering
Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), today announced it has entered into definitive agreements with investors for the purchase and sale of
Lineage Cell Therapeutics Provides End of Year Shareholder Letter
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today provided a year-end review
Congress Extends Critical Legislation Enabling Employers to Enhance Financial Wellness Programs
Gradifi by E*TRADE, a student loan payment benefit administrator, today applauded Congress’ decision to extend critical legislation that preserves for five years the tax-free status of
Navidea Biopharmaceuticals Strengthens Board of Directors with the Appointment of Malcolm Witter
Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today
IMV Reports Update on COVID-19 Vaccine Program
IMV Inc. (Nasdaq: IMV; TSX: IMV) (the “Company”), a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today
Lysogene Reports Positive Biomarker Data With LYS-SAF302
Regulatory News:
Lysogene (FR0013233475 – LYS) (Paris:LYS), a phase 3 gene therapy platform company targeting central nervous system (CNS) diseases, today reports positive biomarker data from the
MedMen Announces Cancellation of 815,295 Class A Super Voting Shares
MedMen Enterprises Inc. (CSE: MMEN) (OTCQX: MMNFF) (“MedMen” or the “Company”), a cannabis retailer with operations across the U.S., today announced that effective as of December 10, 2020, pursuant